Yahoo
Jakarta - Delayed Quote IDR

PT Mitra Keluarga Karyasehat Tbk (MIKA.JK)

1,315.00 +15.00 (+1.15%)
At close: 4:11:49 PM GMT+7
Chart Range Bar
Loading chart for MIKA.JK
  • Previous Close 1,300.00
  • Open 1,300.00
  • Bid 1,315.00 x --
  • Ask 1,320.00 x --
  • Day's Range 1,280.00 - 1,335.00
  • 52 Week Range 1,230.00 - 2,700.00
  • Volume 15,564,600
  • Avg. Volume 4,407,977
  • Market Cap (intraday) 18.264T
  • Beta (5Y Monthly) 0.04
  • PE Ratio (TTM) 12.75
  • EPS (TTM) 103.12
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield 43.00 (3.31%)
  • Ex-Dividend Date Jun 19, 2026
  • 1y Target Est 2,713.33

PT Mitra Keluarga Karyasehat Tbk, together with its subsidiaries, owns and operates hospitals in Indonesia. The company also offers healthcare platform services. Its hospital network comprises Mitra Keluarga Hospitals and Kasih Group Hospitals located in Greater Jakarta, West Java, East Java, and Central Java. The company was founded in 1989 and is headquartered in Jakarta, Indonesia. PT Mitra Keluarga Karyasehat Tbk is a subsidiary of PT Griyainsani Cakrasadaya.

www.mitrakeluarga.com

9,101

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

MIKA.JK
43.20%
IDX COMPOSITE (^JKSE)
43.28%

1-Year Return

MIKA.JK
48.40%
IDX COMPOSITE (^JKSE)
40.73%

3-Year Return

MIKA.JK
47.73%
IDX COMPOSITE (^JKSE)
27.76%

5-Year Return

MIKA.JK
36.81%
IDX COMPOSITE (^JKSE)
25.15%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue --
Earnings 400.8B
Profit Margin 0.00%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500B
1T
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%

Analyst Insights

View More

Analyst Price Targets

1,850.00
2,713.33 Average
1,315.00 Current
3,600.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    25.33%

  • Return on Assets (ttm)

    11.94%

  • Return on Equity (ttm)

    18.36%

  • Revenue (ttm)

    5.66T

  • Net Income Avi to Common (ttm)

    1.43T

  • Diluted EPS (ttm)

    103.12

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.72T

  • Total Debt/Equity (mrq)

    0.10%

  • Levered Free Cash Flow (ttm)

    425.05B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: